AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT05549518 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Core stabilization + Traditional Physical Therapy
Description: In addition to the traditional physical therapy training, core stabilization exercises will be applied 3 days a week for 6 weeks, and 20 minutes in each session under the supervision of a physiotherapist. Core stabilization exercises; will gradually progress from easy exercises to difficult ones. Exercises will be performed in supine, hook position, sitting position, on stable and mobile surfaces. Exercises will progress from 1 set to 3 sets, from 7 to 10 reps, contractions from 3 seconds to 10 seconds. All exercises will be performed with breathing control.~The exercises will be progressed by gradually increasing them every week.
Study NCT05549518 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Traditional Physical Therapy
Description: Traditional physical therapy training will be given for 40 minutes each session, 3 times a week for 6 weeks under the supervision of a physiotherapist. As a traditional physical therapy program, a rehabilitation program that increases mobility and daily living activities will be applied to patients.~* Joint range of motion exercises~* Stretching exercises~* Strengthening exercises~* Bobath-based neurophysiological approaches~* Task-oriented training~* 15 minutes of neuromuscular electrical stimulation (NMES) application
Study NCT05059938 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: MyFitnessPal user
Description: Patients will be counseled on how to use the MyFitnessPal application to help with the patient's weight loss goals. The physician will monitor the patient's weight, blood pressure, and waist circumference over up to a six month period with visits at 1, 3, and 6 months. Patients will be asked about the patient's use of the application at the end of the study.
Study NCT05236959 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Mindfulness-Based Cognitive Therapy
Description: Following an initial interview session, patients are offered eight weekly group-based session, delivered via videoconferencing, and asked to engage in regular daily home practice of mindfulness meditation
Study NCT05685420 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Herombopag
Description: Thrombopoietin receptor agonist
Study NCT05236959 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Treatment as Usual
Description: Following an initial interview session, patients continue with their usual care
Study NCT04639843 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: CC-486 (5-azacitidine)
Description: CC-486 (5-azacitidine) with a dose of 300mg oral intake daily will be given on day 1 to day 10 for 8 cycles.
Study NCT04639843 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Duvelisib
Description: Duvelisib by oral intake at escalating doses of 25, 50 and 75 mg/BID on days -14 to 14 of the 1st cycle then days 1-14 of Cycles 2-8 of each 21- day cycle (max 8 cycles).
Study NCT04639843 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Romidepsin
Description: Romidepsin (12mg/m2) will be administered on days 1 and 8 of each cycle through a peripheral or central intravenous catheter for 8 cycles.
Study NCT04639843 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Doxorubicin
Description: Doxorubicin at 25 mg/ m2 by IV infusion on Day 1 of cycles 3-8.
Study NCT06530121 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Toolbox trainings
Description: Training given with a single page material, lasting between 10-15 minutes, aimed at on-the-job application.
Study NCT04505878 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Vitamin C
Description: Vitamin C is a first-line antioxidant that directly scavenges free radicals, inhibits reactive oxygen species (ROS) producing enzymes and recovers other cellular antioxidants
Study NCT05041621 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Sensor augmented MDI therapy plus mobile application
Description: Participants will use the mobile application to calculate their basal dose and to calculate their meal bolus dose by entering their glucose value, carbs (if applicable), fat composition (high fat or not), and type and timing of postprandial exercises. Participants will receive their dosing parameters weekly upon adjustments made by the reinforcement learning algorithm. Participants will be contacted by telephone on Weeks 1, 3, 5, and 7 in case of any technical difficulties or questions.~All participants will be asked to complete the:~(i) Diabetes treatment satisfaction questionnaire (DTSQ) and hypoglycemia fear survey-II (HFS-II) at baseline, halfway through the intervention, and post-intervention.~(ii) mHealth usability questionnaire (MAUQ) at post-intervention.
Study NCT05975138 — intervention group
Intervention type: PROCEDURE
Intervention: implant insertion
Description: a minimally invasive full-thickness flap will be raised in order to visualize the anatomy of the ridge. The vertical thickness of the supracrestal soft tissue will be measured and recorded. The preparation of the implant site will be performed with rotary burs and the bone quality will be recorded. An implant will be placed according to the manufacturer's recommendations. The length of the implant will be chosen in order to obtain a bicortical anchorage on the floor of the maxillary sinus
Study NCT05274061 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Accelerated, Intensive, Multi-Couple Cognitive Behavioral Couples Therapy
Description: AIM-CBCT consists of an accelerated, 2-day delivery of the first 7 sessions of CBCT for PTSD and is comprised of (a) psychoeducation about PTSD and relationship functioning; (b) instruction in conflict management skills; (c) instruction in effective communication skills with an emphasis on the identification and sharing of emotions to decrease emotional numbing and increase emotional intimacy; (d) discussion of the importance of approaching, rather than avoiding, difficult situations and identification of places, situations, people, and feelings that the couple has heretofore avoided as a result of PTSD; (e) instruction in identification of thoughts and related feelings that can maintain PTSD and relationship distress and strategies to increase cognitive flexibility, and (f) instruction in problem-solving skills to generate couple-level approach behaviors and guidance in how to select activities that double as opportunities to approach feared situations and engage in positive bonding.
Study NCT05034614 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: OTHER
Intervention: Papette brush collection
Description: Cervical cell brush that gathers collects cervical cells during Pap smear collection
Study NCT05034614 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: OTHER
Intervention: Spatula/cytology brush collection
Description: Combination of extended-tip spatula with endocervical brush that collects cervical cells during Pap smear collection
Study NCT05280275 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Belantamab Mafodotin-Blmf
Description: Blmf will be available as 100 mg/vial in single-use vial for reconstitution, supplied as lyophilized powder.~Blmf will be delivered as IV solution over at least 30 minutes.
Study NCT05280275 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Daratumumab
Description: Daratumumab will be administered with subcutaneous injections. On days where Blmf is given together with daratumumab, daratumumab should be performed first.
Study NCT05280275 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Lenalidomide
Description: Lenalidomide will be administered per os.
Study NCT05280275 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Dexamethasone
Description: Dexamethasone will be administered intravenously or per os.
Study NCT05227209 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: SEP-4199 CR
Description: SEP-4199 CR either 200 mg (one 200 mg tablet) or 400 mg (two 200 mg tablets) once daily
Study NCT05545410 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: MRI calibration
Description: Non-injected thoracic aorta MRI calibration
Study NCT06401499 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: etoricoxib 60mg
Description: investigator will compare effects of etoricoxib alone and in combination with pregabalin on pain relief in chronic low back pain participants
Study NCT05152290 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: AlloRx
Description: cultured allogeneic adult umbilical cord derived mesenchymal stem cells
Study NCT05646420 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Blood sampling
Description: A blood sample of 15 ml will be collected for each patient.
Study NCT06295848 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Exercise
Description: An individual program will be organized for each patient according to the exercise test result. Since the patients have both arthritis and HTN, aerobic exercises will be given at moderate intensity (40-60% VO2 reserve) according to ACMS recommendations. Xrcise Runner Med treadmill and Xrcise Care 2.5.8.3 software will be used for aerobic exercises. Resistant exercises will be given under the supervision of a physiotherapist, calculating 1 repetitation maximum (1-RM) in the main muscle groups.Patients will perform isotonic exercises with 3 sets of 15 repetitions with a resistance of 60% of 1-RM. The education sessions will be conducted by a multidisciplinary team of health professionals (nurse, physiotherapist and dietician) under the leadership of a clinician experienced in CR. Education topics will consist of 60-minute sessions covering heart-healthy eating, setting health-related goal, exercise, diet, healthy weight loss, smoking cessation, and stress/coping.
Study NCT06386926 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Electro Therapy
Description: radial shockwave 3 sessions one session per week for four consecutive weeks ,receive Ultrasound phonophoresis using diclofenac Na+ 12 session, 3 sessions per week and conventional physical therapy modalities in the form of 3 sessions every week for 8 weeks
Study NCT06386926 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Electro Therapy
Description: radial shockwave 3 sessions one session per week for four consecutive weeks ,receive Ultrasound phonophoresis using diclofenac Na+ 12 session, 3 sessions per week and conventional physical therapy modalities in the form of 3 sessions every week for 8 weeks
Study NCT06241716 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Ultrasound-assisted localization, US-AS
Description: In the US-AS group, ultrasonic prescan to determine the best intervertebral space, best puncture Angle and best puncture depth. The optimal puncture section considered by the operator was selected to record the best gap, puncture Angle and depth.
Study NCT06241716 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Ultrasound-assisted localization, US-AS
Description: In the US-AS group, ultrasonic prescan to determine the best intervertebral space, best puncture Angle and best puncture depth. The optimal puncture section considered by the operator was selected to record the best gap, puncture Angle and depth.
Study NCT06241716 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Real-time ultrasound guidance, US-RTG
Description: In the US-RTG group, the optimal puncture section considered by the operator was selected and recorded directly in the plane of the paracentral transverse section, out of the plane of the paracentral sagittal section or in the plane of the paracentral sagittal section for real-time ultrasound guided lumbar epidural anesthesia.
Study NCT06241716 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Real-time ultrasound guidance, US-RTG
Description: In the US-RTG group, the optimal puncture section considered by the operator was selected and recorded directly in the plane of the paracentral transverse section, out of the plane of the paracentral sagittal section or in the plane of the paracentral sagittal section for real-time ultrasound guided lumbar epidural anesthesia.
Study NCT05758766 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Plant-based omega-3-FA
Description: Plant-based omega 3 Fatty Acids
Study NCT05747716 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: SBRT, Fruquintinib, Cadonilimab
Description: Radiation: Stereotactic body radiationtherapy (SBRT) for metastatic sites (less than 5) Fruquintinib: 5mg, po, everyday; Cadonilimab: 10mg/kg, iv, q3w
Study NCT05453448 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: tenofovir alafenamide
Description: Antiviral therapy
Study NCT05453448 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Entecavir
Description: entecavir
Study NCT04948814 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Fecal microbiota transplantation
Description: FMT utilizing stool from healthy children
Study NCT04948814 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Vancomycin
Description: 40mg/kg/day
Study NCT05369507 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Virtual Care Coordination
Description: Participants randomly assigned to the virtual care coordination group will use a mobile app to assist in HCV treatment care coordination.
Study NCT05282875 — intervention group
Intervention type: DRUG
Intervention: management of immunosuppressive therapy
Description: 3 groups :~* Discontinuation of immunosuppressive agents~* Reduction of immunosuppressive agents~* Maintenance of immunosuppressive agents
Study NCT05794880 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Magnetic-Activated Cell Sorter (CliniMACS, Miltenyi)
Description: Participants in this study will receive a blood stem cell transplant, which will use an investigational device called the CliniMACs device to remove alpha/beta T cells and B cells from the blood cells collected from the donor. This is called T cell depletion and B cell depletion.
Study NCT04712123 — intervention group
Intervention type: OTHER
Intervention: relapse due to S. aureus
Description: to find out if it is the same S. aureus in both infections
Study NCT05130684 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Nivolumab
Description: adding nivolumab to conventional neoadjuvant CRT
Study NCT04815681 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Common Elements Toolbox
Description: COMET is an online unguided self-help intervention that lasts approximately 40-50 minutes.
Study NCT04815681 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Active Control
Description: The active control condition includes an online self-awareness program that lasts approximately 40-50 minutes. Participants in the control condition will receive access to the intervention after data collection for the study has been completed.
Study NCT05683964 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Apalutamide [Erleada], darolutamide [Nubeqa], or enzalutamide [Xtandi]
Description: per standard care
Study NCT05683964 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: Prostate-Specific Membrane Antigen (PSMA) PET/CT Scan
Description: Per standard care
Study NCT05694767 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: CM313 Injection
Description: intravenous CM313 administration~This study adopts a prospective, single arm, open design method. Twenty subjects were enrolled in the study and were treated with CD38 monoclonal antibody (CM 313: 16mg/kg/w) for 8 weeks.~The first stage is the main research stage (d1-w8), which is the core treatment period. The subjects will receive intravenous infusion of 16mg/kg CM313 once a week for 8 weeks to observe the safety and efficacy during treatment.~The second stage (w9-w24) is the stage of withdrawal from the visit, mainly to observe the safety and continuous efficacy of CM313 after treatment.
Study NCT04784754 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Melatonin
Description: Melatonin capsules will be prepared using hypromellose capsules containing 3 mg or 30 mg of the active component and identical excipient (Microcrystalline Cellulose) used in the placebo preparation. Melatonin will be administered orally three times a day for 14 days.
Study NCT05124314 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Mifepristone, Oral, 200 Mg
Description: Adding 600 mg of oral Mifepristone to the regular treatment with vaginal Misoprostol 800 mcg
Study NCT05124314 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Misoprostol Pill
Description: Regular treatment with vaginal Misoprostol 800 mcg
Study NCT05124314 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Misoprostol Pill
Description: Regular treatment with vaginal Misoprostol 800 mcg
Study NCT05528185 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Direct participation of the family member in the daily rounds
Description: When the team arrives at the participating family member's room, the family member will be invited by a member of the healthcare team to come out of the room. The rounding team and structure will be the same as the usual care group with the following exceptions: (1) the family member will be invited to participate in the rounds outside their relative's room; (2) the family member will be provided with an orientation to the medical team members; (3) the family member will be allowed to engage and participate throughout the rounds; (4) at the end of the rounds, the team will summarize the patient's daily care plan; (5) the family member will be prompted to ask questions.
Study NCT04784754 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo capsules will be prepared using hypromellose capsules, filled using microcrystalline cellulose. This is the same excipient used in the preparation of the interventional drug. Placebo will be administered orally three times a day for 14 days in the same regimen used for the intervention.
Study NCT05575544 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Acupuncture plus morphine
Description: The acupuncture was combined with intravenous use of morphine to achieve anesthesia during the ablation procedure
Study NCT05196373 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: STP705
Description: STP705 Powder for Injection composed of siRNA-TGF-B1 and siRNA-COX-2 packged in a proprietary polymer nanoparticle formulation for delivery.
Study NCT06306326 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: 3dMD technology
Description: By taking photos using 3dMD, we obtained preoperative, immediate postoperative, and long-term postoperative three-dimensional data of patients. The software automatically fused the data to obtain the volume difference of facial volume at different time points, and then divided it to obtain the objective data of facial volume improvement rate. To improve the reliability of the measurements, two researchers measured independently and took the average value.
Study NCT06580470 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Tailored Cognitive Behavioral Therapy for Menopause
Description: Cognitive Behavioral Therapy for Menopause (CBT-Meno) is an evidenced-based intervention that includes psychoeducation, cognitive, and behavioral strategies for coping with common menopause symptoms and experiences. In Aims 1 and 2, CBT-Meno materials and procedures will be tailored for women Veterans through an iterative process involving: a) data from preliminary studies and a pre-pilot trial; b) input from content area experts; and c) stakeholder advisory panels. This tailored version of CBT-Meno will then be test in this clinical trial.
Study NCT06360471 — intervention group
Intervention type: OTHER
Intervention: fertility preservation
Description: If a patient have a desire to fertility preservation, oocyte freezing or embryo freezing will be offered.
Study NCT04783870 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Dapagliflozin
Description: Dapagliflozin 10 mg PO QD
Study NCT04783870 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo
Study NCT05706961 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Power Walking
Description: For 1- 2 Week 60% of the target heart rate with 5,000 to 7,500 steps/day Total 30 min Session The exercise intensity was set at 60% of the target heart rate during the first 2 weeks.~For 3- 4 week 70 % of the target heart rate with 7,500 to 10,000 steps/day Total 30 min Session B) Progressive increase walk according to 6MWD as improved Low intensity
Study NCT05706961 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Standardized Outpatient Cardiac Rehabilitation
Description: For 1- 2 week Standardized Outpatient Cardiac Rehabilitation (includes warm up of 5 min, aerobic 60 % of of target heart rate, resistive ex with 1- 3 kg of weight for 20 min and 10 min of cool down)~For 3 - 4 week Standardized Outpatient Cardiac Rehabilitation (includes warm up of 5 min, aerobic 70 % of target heart rate, resistive ex with 2- 3 kg of weight for 20 min and 10 min of cool down)
Study NCT04751968 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Group Intervention
Description: The intervention will consist of 6 psycho-educational group sessions for caregivers and 6 psycho-educational group sessions for adolescents. Adolescent and caregiver sessions will be held separately and will focus on different issues. Adolescents are taught skills for coping and relating more effectively with others. Caregivers learn about adolescent development, effective parenting and the importance of connection. The groups consist of 6 stand-alone modules permitting rolling entry and prompt access. Youth and Caregivers will receive a weekly text message reminder of their exit assessment date/time, homework from that week's intervention group and crisis resources.
Study NCT04751968 — intervention group
Intervention type: BEHAVIORAL
Group type: OTHER
Intervention: Enhanced Treatment as Usual
Description: Youth and Caregivers will receive a weekly text message reminder of their exit assessment date/time, a mental health tip and crisis resources.